EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY EGX:PHAR:
EIPICO 3 FACILITY GETS EGYPTIAN DRUG AUTHORITY (EDA) APPROVAL AND INTRODUCES ITS FIRST BIOLOGICAL PRODUCT "ADALIMAB"
EDA APPROVAL PREPARES GROUND FOR STARTING OPERATIONS IN Q1 OF 2026
RECEIVES FORMAL REQUEST AND PURCHASE ORDER TO SUPPLY ADALIMAB TO NAMIBIA